Page 13 - வெளிப்படையான ர் லாஸ் ஏஞ்சல்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus vaccines won’t be available for children under 12 until after school starts. Pfizer expects to know how its vaccine performs among kids ages 5 to 11 by the end of September. Moderna could seek FDA authorization in the winter or early next year. It’s one of the US’s biggest hurdles to getting the population vaccinated: Children under 12 – nearly 15% of the country, or around 48 million Americans – aren’t yet eligible to receive coronavirus shots. Both Pfizer and Moderna entered young kids into their clinical trials in March, but the results of those studies haven’t been published yet. Pfizer expects to have data about its vaccine’s efficacy among kids ages 5 to 11 by the end of September. It usually takes the Food and Drug Administration a few weeks to review such data, so that would put the US on track to start administering shots to young kids in October at the earliest, assuming the trial results are good.

United statesNew yorkTel avivLos angelesMonserat ramosFrancine orr los angelesMalikai mcphersonNew york timesDrug administrationLos angeles timesGetty imagesஒன்றுபட்டது மாநிலங்களில்புதியது யார்க்தொலைபேசி அவிவ்லாஸ் ஏஞ்சல்ஸ்வெளிப்படையான ர் லாஸ் ஏஞ்சல்ஸ்